Zymeworks Inc ZYME Price Prediction & Forecast



Forecast

ZYME Stock Price Prediction

Zymeworks Inc

0%

$0

At close: May 01, 16:00:00 GMT-4

0%

$0

Post-market: May 01, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is ZYME?

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. The company is headquartered in Middletown, Delaware and currently employs 264 full-time employees. The company went IPO on 2019-06-24. The firm is developing a diverse pipeline of multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases such as cancer, autoimmune and inflammatory diseases (AIID). The firm engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company’s Azymetric technology. The company has entered into separate agreements with BeiGene, Ltd. and Jazz Pharmaceuticals Ireland Limited, granting each exclusive rights to develop and commercialize zanidatamab in different territories. The company is advancing a pipeline of wholly-owned product candidates, leveraging its expertise in both antibody-drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. The firm has two clinical-stage product candidates: ZW171 and ZW191. Its preclinical product candidates include ZW251, ZW220, ZW209, and ZW1528.

Features

Markets

News

ZYME Stock Price Prediction Summary

ZYME stock price ended at $0 on Sunday, after dropping NaN%

On the latest trading day May 03, 2026, the stock price of ZYME fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for ZYME decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.

ZYME Technical Signals

Technical Signals Summary

Buy Signals 0

Neutral Signals 7

Sell Signals 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

ZYME currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.

Bullish/Bearish Signals for ZYME

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for ZYME. These insights help you make informed investment decisions.

Follow-Up Questions

How do technical analysis indicators apply to ZYME?



According to technical analysis, Zymeworks Inc has an aggregate signal of Neutral. Zymeworks Inc has 0 Buy signals, 7 Neutral Signals and 0 sell signals.

What is the RSI for Zymeworks Inc?



The RSI for Zymeworks Inc is currently 0, indicating a neutral condition

What is Zymeworks Inc price for the next 12 months?



Zymeworks Inc ZYME price for the next 12 months is estimated at $0.

How high is Zymeworks Inc expected to go?



According to wall street analysts, Zymeworks Inc is expected to reach a high forecast of $0.

Zymeworks Inc (ZYME) Stock Price Prediction

ZYME Stock Price Chart